| Source Date | Board Meeting Date | Details |
|
23-Aug-2024
|
28-Aug-2024
|
Preferential Issue of shares & Inter alia, to consider and approve:- 1. To approve Draft Director?s Report of the company for the year 2023-24. 2. To ratify the material related party transactions entered by the company on arm?s length prices during the year 2023-24. 3. To approve Material related party transactions with Biovivid Labs Pharmaceuticals Private Limited for FY 2024-25. 4. To approve Material related party transactions with Manbro Polymers Limited for FY 2024-25. 5. To consider and approve an increase in Authorized share capital of the Company by 5 Crores and subsequent alteration of the capital clause of the memorandum of association. 6. To consider a proposal for fund raising by way of issue of equity shares/convertible warrants and or/any other instruments through preferential issue subject to the approval of the shareholders of the Company and such regulatory/statutory approvals as may be required, in this regard.
|
|
07-Aug-2024
|
14-Aug-2024
|
Quarterly Results
|
|
27-May-2024
|
30-May-2024
|
Audited Results
|
|
07-Feb-2024
|
14-Feb-2024
|
Quarterly Results
|
|
06-Nov-2023
|
10-Nov-2023
|
Quarterly Results
|
|
25-Sep-2023
|
03-Oct-2023
|
Right Issue of Equity Shares
|
|
07-Aug-2023
|
11-Aug-2023
|
Quarterly Results
|
|
23-May-2023
|
30-May-2023
|
Quarterly Results & Audited Results
|
|
06-Feb-2023
|
13-Feb-2023
|
Quarterly Results
|
|
09-Nov-2022
|
14-Nov-2022
|
Quarterly Results
|